RT @iMarkAnderson: Research 👩🔬👨🔬 into the effectiveness of #Modafinil and other wake-promoting agents in #narcolepsy continues. Here's an…
Research 👩🔬👨🔬 into the effectiveness of #Modafinil and other wake-promoting agents in #narcolepsy continues. Here's another comparison article in the public domain 👌 https://t.co/vDm22Y2eMU #nootropics #smart_drugs #Modafinil_org
RT @Andre_AGTC: $AXSM Sunosi (from Jazz) outperforming the other drugs in EDS narcolepcy They have in Ph3 AXS-12 which is for cataplexy in…
RT @Andre_AGTC: $AXSM Sunosi (from Jazz) outperforming the other drugs in EDS narcolepcy They have in Ph3 AXS-12 which is for cataplexy in…
RT @Andre_AGTC: $AXSM Sunosi (from Jazz) outperforming the other drugs in EDS narcolepcy They have in Ph3 AXS-12 which is for cataplexy in…
$AXSM Sunosi (from Jazz) outperforming the other drugs in EDS narcolepcy They have in Ph3 AXS-12 which is for cataplexy in narcolepcy. If successful, they will own the narcolepcy market w 2 key drugs, projected market size $6.6B in 2030.
@semodough There is also an April paper showing Sunosi outperformed 4 other frequently used drugs in a 17 trial comparison for EDS in Narcolepsy. https://t.co/3talaPsm66